Galectin Therapeutics (GALT) Insider Trading & Ownership $2.78 +0.06 (+2.21%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Galectin Therapeutics (NASDAQ:GALT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage52.70%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$34,100.70Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$65,248.38 Get GALT Insider Trade Alerts Want to know when executives and insiders are buying or selling Galectin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GALT Insider Buying and Selling by Quarter Ad Brownstone ResearchShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Click here for full details. Galectin Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/23/2024Kary EldredDirectorBuy500$2.60$1,300.00 10/16/2024Kevin D FreemanDirectorBuy5,000$2.70$13,500.00 8/23/2024Richard A Jr. ZordaniDirectorBuy1,759$2.30$4,045.70 4/30/2024Richard A Jr. ZordaniDirectorBuy1,000$3.52$3,520.00 4/24/2024Joel LewisCEOBuy1,000$3.39$3,390.00 4/22/2024James C CzirrMajor ShareholderSell21,323$3.06$65,248.38 4/22/2024Kevin D FreemanDirectorBuy2,500$2.98$7,450.00 1/16/2024Kary EldredDirectorBuy500$1.79$895.00 (Data available from 1/1/2013 forward) GALT Insider Trading Activity - Frequently Asked Questions Who is on Galectin Therapeutics's Insider Roster? The list of insiders at Galectin Therapeutics includes Elissa J Schwartz, Fund L.P. 10X, Jack W Callicutt, James C Czirr, Joel Lewis, Kary Eldred, Kevin D Freeman, and Richard A Jr. Zordani. Learn more on insiders at GALT. What percentage of Galectin Therapeutics stock is owned by insiders? 52.70% of Galectin Therapeutics stock is owned by insiders. Learn more on GALT's insider holdings. Which Galectin Therapeutics insiders have been buying company stock? The following insiders have purchased GALT shares in the last 24 months: Joel Lewis ($4,910.00), Kary Eldred ($8,088.42), Kevin D Freeman ($20,950.00), and Richard A Jr. Zordani ($7,565.70). How much insider buying is happening at Galectin Therapeutics? Insiders have purchased a total of 17,157 GALT shares in the last 24 months for a total of $41,514.12 bought. Which Galectin Therapeutics insiders have been selling company stock? The following insider sold GALT shares in the last 24 months: James C Czirr ($65,248.38). How much insider selling is happening at Galectin Therapeutics? Insiders have sold a total of 21,323 Galectin Therapeutics shares in the last 24 months for a total of $65,248.38 sold. Galectin Therapeutics Key ExecutivesMr. Joel Lewis (Age 54)President, CEO & Director Compensation: $907.72kMr. Jack W. Callicutt CPA (Age 57)CFO, Treasurer & Corporate Secretary Compensation: $521.47kDr. Pol F. Boudes M.D. (Age 67)Ph.D., Chief Medical Officer Compensation: $730.33kRobert TrittGeneral CounselMr. Jeff KatstraHead of CMC & Pharmaceutical DevelopmentMs. Beth KnowlesExecutive Assistant & Officer Manager More Insider Trading Tools from MarketBeat Related Companies Lumos Pharma Insider Transactions Entrada Therapeutics Insider Transactions Tectonic Therapeutic Insider Transactions AnaptysBio Insider Transactions Phathom Pharmaceuticals Insider Transactions ORIC Pharmaceuticals Insider Transactions CorMedix Insider Transactions Stoke Therapeutics Insider Transactions Altimmune Insider Transactions Dianthus Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:GALT) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galectin Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galectin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
